DSGN
Price
$4.25
Change
+$0.20 (+4.94%)
Updated
Jul 22, 04:59 PM (EDT)
Capitalization
229.91M
20 days until earnings call
PVLA
Price
$35.99
Change
+$4.99 (+16.10%)
Updated
Jul 22, 04:59 PM (EDT)
Capitalization
342.73M
Interact to see
Advertisement

DSGN vs PVLA

Header iconDSGN vs PVLA Comparison
Open Charts DSGN vs PVLABanner chart's image
Design Therapeutics
Price$4.25
Change+$0.20 (+4.94%)
Volume$606
Capitalization229.91M
Palvella Therapeutics
Price$35.99
Change+$4.99 (+16.10%)
Volume$5.67K
Capitalization342.73M
DSGN vs PVLA Comparison Chart in %
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. PVLA commentary
Jul 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and PVLA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 23, 2025
Stock price -- (DSGN: $4.05 vs. PVLA: $31.00)
Brand notoriety: DSGN and PVLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 80% vs. PVLA: 115%
Market capitalization -- DSGN: $229.91M vs. PVLA: $342.73M
DSGN [@Biotechnology] is valued at $229.91M. PVLA’s [@Biotechnology] market capitalization is $342.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whilePVLA’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • PVLA’s FA Score: 1 green, 4 red.
According to our system of comparison, PVLA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while PVLA’s TA Score has 6 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 4 bearish.
  • PVLA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PVLA is a better buy in the short-term than DSGN.

Price Growth

DSGN (@Biotechnology) experienced а +1.25% price change this week, while PVLA (@Biotechnology) price change was +12.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.09%. For the same industry, the average monthly price growth was +19.23%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

DSGN is expected to report earnings on Nov 05, 2025.

PVLA is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+7.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($343M) has a higher market cap than DSGN($230M). PVLA YTD gains are higher at: 158.333 vs. DSGN (-34.360). PVLA has higher annual earnings (EBITDA): -18.36M vs. DSGN (-67.79M). DSGN has more cash in the bank: 230M vs. PVLA (75.6M). DSGN (0) and PVLA (0) have equivalent revenues.
DSGNPVLADSGN / PVLA
Capitalization230M343M67%
EBITDA-67.79M-18.36M369%
Gain YTD-34.360158.333-22%
P/E RatioN/A14.22-
Revenue00-
Total Cash230M75.6M304%
Total Debt2.14MN/A-
FUNDAMENTALS RATINGS
PVLA: Fundamental Ratings
PVLA
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNPVLA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 14 days ago
88%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 27 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGZFF0.12N/A
+0.60%
Pan Global Resource, Inc.
ABVN0.89N/A
N/A
ABV Consulting Inc.
HMRZF13.54N/A
N/A
Hennes & Mauritz AB
SUOPY16.06N/A
N/A
Sumco Corp.
MADGF4.76N/A
N/A
MADER GROUP LTD

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+1.76%
VRDN - DSGN
49%
Loosely correlated
+1.63%
IDYA - DSGN
49%
Loosely correlated
+1.02%
KRYS - DSGN
47%
Loosely correlated
+0.41%
AURA - DSGN
45%
Loosely correlated
+0.89%
NTLA - DSGN
44%
Loosely correlated
+4.73%
More

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with DRMA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then DRMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
+5.05%
DRMA - PVLA
39%
Loosely correlated
+6.22%
DSGN - PVLA
31%
Poorly correlated
+1.76%
KPRX - PVLA
26%
Poorly correlated
-2.83%
PTGX - PVLA
26%
Poorly correlated
-0.47%
XNCR - PVLA
26%
Poorly correlated
+1.45%
More